×
AllNewsImagesVideos Maps Shopping Books
Search tools
Did you mean: Newton Pharmaceut.

Despite Lacking Profits Newron Pharmaceuticals (VTX:NWRN) Seems To Be On Top Of Its Debt

Yahoo Movies UK
Legendary fund manager Li Lu (who Charlie Munger backed) once said, 'The biggest investment risk is not the volatility...
1 day ago

Newron shares shoot up on potentially pivotal schizophrenia data

The Pharma Letter
Italy-based biopharma Newron Pharmaceuticals was trading 14% higher at lunchtime on Tuesday.
3 days ago

Newron Presents 2023 Financial Results and Provides 2024 Outlook

Business Wire
MILAN--(BUSINESS WIRE)--Newron Pharmaceuticals S.p.A. (“Newron”) (SIX: NWRN, XETRA: NP5), a biopharmaceutical company focused on the...
1 month ago

Newron's evenamide brings good news for patients with CNS diseases

outsourcing-pharma.com
Positive results of a study into the effects of an add-on to antipsychotics for the management of treatment-resistant schizophrenia (TRS)...
3 months ago

Court of Appeal upholds UKIPO rejection of SPC for Parkinson's treatment

JUVE Patent
The UK Court of Appeal has dismissed an appeal brought by Newron Pharmaceuticals regarding the meaning of 'product' in pharmaceutical...
2 months ago

Newron enrols all subjects in schizophrenia treatment trial

Clinical Trials Arena
Newron Pharmaceuticals has finished enrolling subjects in a trial of evenamide to assess its potential to treat patients with schizophrenia.
4 months ago

Newron Pharmaceuticals Full Year 2023 Earnings: Revenues Beat Expectations, EPS In Line

Simply Wall St
Newron Pharmaceuticals ( VTX:NWRN ) Full Year 2023 Results Key Financial Results Revenue: €9.06m (up 49% from FY 2022...
1 month ago

Newron Pharmaceuticals (OTCMKTS:NWPHF) and Tenax Therapeutics (NASDAQ:TENX) Critical Comparison

Defense World
Read Newron Pharmaceuticals (OTCMKTS:NWPHF) and Tenax Therapeutics (NASDAQ:TENX) Critical Comparison at Defense World.
1 week ago

Newron Reports Exceptional One-year Results of Study 014/15 With Evenamide in Treatment-resistant Schizophrenia ...

Business Wire
Newron reports exceptional one-year clinical results with evenamide for treatment-resistant schizophrenia (TRS). Conference call today at...
3 months ago

'Remarkable' effect of evenamide, Newron's schizophrenia drug

outsourcing-pharma.com
The unique glutamatergic mechanism of action in Newron Pharmaceuticals' investigational new drug can potentially produce a long-lasting...
6 months ago